We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$370M
AUM Growth
+$95.8M
Cap. Flow
+$47.5M
Cap. Flow %
12.83%
Top 10 Hldgs %
36.28%
Holding
91
New
23
Increased
27
Reduced
13
Closed
22

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$24.7M
2
CVS icon
CVS Health
CVS
+$13.7M
3
GSK icon
GSK
GSK
+$10.5M
4
GILD icon
Gilead Sciences
GILD
+$9.94M
5
GMED icon
Globus Medical
GMED
+$9.18M

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$9.96M
2
CI icon
Cigna
CI
+$9.92M
3
CAH icon
Cardinal Health
CAH
+$9.32M
4
CELG
Celgene Corp
CELG
+$6.56M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.31M

Sector Composition

Rank Sector Weight
1 Healthcare 87.37%
2 Miscellaneous 11.53%
3 Industrials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$119B
$19.8M 5.34%
367,071
+222,294
+154% +$13.7M
BIIB icon
2
Biogen
BIIB
$32.3B
$18.6M 5.02%
+78,596
New +$24.7M
GILD icon
3
Gilead Sciences
GILD
$181B
$16M 4.32%
245,968
+149,488
+155% +$9.94M
HCA icon
4
HCA Healthcare
HCA
$90.5B
$14M 3.78%
107,428
+39,389
+58% +$5.29M
MDT icon
5
Medtronic
MDT
$117B
$12M 3.23%
131,464
+349
+0.3% +$31.2K
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$11.2M 3.03%
766,980
+323,571
+73% +$3.72M
GSK icon
7
GSK
GSK
$102B
$10.9M 2.96%
+209,600
New +$10.5M
MEDP icon
8
Medpace
MEDP
$16.8B
$10.7M 2.9%
181,866
+118,686
+188% +$7.09M
ASND icon
9
Ascendis Pharma A/S
ASND
$16.3B
$10.6M 2.87%
+90,325
New +$7.91M
GWPH
10
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$10.5M 2.83%
62,186
-22,000
-26% -$3.27M
WBA
11
PUT
DELISTED
Walgreens Boots Alliance
WBA
$10.5M 2.83%
+165,500
New +$11.3M
GMED icon
12
Globus Medical
GMED
$11.1B
$10M 2.71%
+202,827
New +$9.18M
EBS icon
13
Emergent Biosolutions
EBS
$303M
$9.1M 2.46%
180,156
+106,363
+144% +$6.27M
GWPH
14
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$8.56M 2.31%
+50,800
New +$7.56M
NVO
15
Novo Nordisk
NVO
$202B
$8.47M 2.29%
324,000
+29,244
+10% +$719K
VKTX icon
16
Viking Therapeutics
VKTX
$3.75B
$8.47M 2.29%
852,160
+215,114
+34% +$1.8M
ALNY icon
17
Alnylam Pharmaceuticals
ALNY
$31.7B
$7.4M 2%
79,153
-75,484
-49% -$6.31M
CCXI
18
DELISTED
ChemoCentryx, Inc.
CCXI
$7.36M 1.99%
530,175
+360,918
+213% +$4.13M
LITS
19
Lite Strategy Inc
LITS
$33.4M
$7.24M 1.95%
117,832
-860
-0.7% -$49.3K
SNY icon
20
Sanofi
SNY
$107B
$6.95M 1.88%
156,854
-111,534
-42% -$4.78M
MOH icon
21
Molina Healthcare
MOH
$10.4B
$6.38M 1.72%
44,928
+2,059
+5% +$278K
MCK icon
22
McKesson
MCK
$104B
$6M 1.62%
51,300
+4,770
+10% +$589K
SPPI
23
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$5.92M 1.6%
+554,019
New +$5.93M
WCG
24
DELISTED
Wellcare Health Plans, Inc.
WCG
$5.79M 1.56%
+21,459
New +$5.54M
ISRG icon
25
PUT
Intuitive Surgical
ISRG
$132B
$5.65M 1.53%
+29,700
New +$5.28M
1
2 3 4

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Sio Capital Management held 91 positions worth $370M, up 35% from $275M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sio Capital Management deployed $47.5M of net new capital in Q1 2019, opening 23 new positions and adding to 27 existing holdings. Its largest new stake was Biogen: 78,596 shares worth $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 95% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $6.31M trimmed.

  • Sio Capital Management's largest Q1 2019 buy was Biogen: 78,596 shares worth $18.6M.
  • Sio Capital Management added most to CVS Health in Q1 2019, an estimated $13.7M increase.
  • Sio Capital Management's biggest Q1 2019 reduction was Alnylam Pharmaceuticals, cutting an estimated $6.31M.
  • Sio Capital Management fully exited Cencora in Q1 2019, selling an estimated $9.96M.
  • Sio Capital Management's ten largest holdings make up 36% of its $370M portfolio in Q1 2019.
  • Sio Capital Management opened 23 new positions and closed 22 in Q1 2019.
  • Sio Capital Management's portfolio value rose 35% quarter-over-quarter to $370M.

Based on Sio Capital Management's 13F filing for Q1 2019, filed 15 May 2019.